Introduction {#s1}
============

A laboratory critical value refers to an extremely abnormal laboratory test result which may be life threatening if treatment is not initiated immediately. This concept was first introduced by Lundberg in 1972 and has been widely adopted worldwide [@pone.0059518-Lundberg1]. The Joint Commission International, ISO 15189 and the College of American Pathologists all have clear requirements on the identification, handling, documentation and auditing of laboratory critical value [@pone.0059518-International1]--[@pone.0059518-The1]. The Chinese Hospital Association also made the reporting of critical value one of the National Patient Safety Goals from 2007 to 2011 [@pone.0059518-ChineseMedicalDoctor1]. It is expected that all laboratories establish a critical value list with ranges based on hospital size and specialties. Also important to consider are the impact on laboratory and physician time as well as user input on which values are included [@pone.0059518-Lundberg1]--[@pone.0059518-ChineseMedicalDoctor1]. The number of critical values will influence laboratory workload, clinical care and treatment. Excluding the time nurses and physicians require when dealing with the critical value, laboratory personnel need 4--6 minutes to complete a critical value call for hospital inpatients and 11--14 minutes to complete a call for outpatients [@pone.0059518-Howanitz1], [@pone.0059518-Valenstein1].

There are some common practices for laboratory critical value policy, such as the list, the range and the reporting procedure [@pone.0059518-Kost1]. However, little information is available on repeat critical values or subsequent critical values for the same analyte(s) on the same patient. Studies by Howanitz et al. [@pone.0059518-Howanitz2], [@pone.0059518-Howanitz3] implied that both whole blood sodium and total serum calcium alerts can occur in the same patient more than once. However, it was not clear which laboratory tests were prone to repeat critical values and there were very few data on the distribution of such values. Additionally, we have no idea whether patients who had more repeat critical values on a certain test item had a worse outcome compared to those who only had one critical value. This would have some implication on the reporting of subsequent repeat critical values. The literature is full of inconsistencies on this issue and different hospitals have their differing practices, such as calling for only the first critical value, calling for each critical value, calling for worsening values, or calling for critical values once per interval of time [@pone.0059518-Howanitz1], [@pone.0059518-Valenstein1], [@pone.0059518-Genzen1]--[@pone.0059518-Dighe1]. Reporting of laboratory repeat critical values is an issue worthy attention because of important regulatory, legal and clinical concerns.

We analyzed 11 laboratory critical value test items, including chemistry and hematology analytes, from a large tertiary hospital in China in the year 2010. Our aim was to explore the incidence and distribution of repeat critical values, including single analyte repeat critical values, multiple analytes repeat critical values and the interval time for each single analyte repeat critical values. We also used serum potassium and platelet count as examples to retrospectively analyze the relationship between the frequency of repeat critical values and the length of hospital stay and patient outcome. All of this information will serve to guide laboratories on how to improve reporting policies for repeat critical values.

Materials and Methods {#s2}
=====================

Setting {#s2a}
-------

The First Affiliated Hospital, School of Medicine, Zhejiang University, is an adult comprehensive tertiary teaching hospital in Hangzhou, Zhejiang Province, P.R. China. There are currently 2,800 beds in the hospital. Its clinical laboratory is a national clinical key specialty lab, with sub-specialties such as clinical hematology, biochemistry, and immunology. The laboratory attained ISO 15189 certification in October 2011. The critical value list including the test items and ranges from 2010 is shown in [Table 1](#pone-0059518-t001){ref-type="table"}. This list was typical of tertiary hospitals in China. It was based on reports from the College of American Pathologists [@pone.0059518-Howanitz1], [@pone.0059518-Dighe2] and the patient safety requirements of the Chinese Hospital Association [@pone.0059518-ChineseMedicalDoctor1], with consultation from relevant clinical experts and was approved by the hospital Medical Quality Committee.
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###### The critical value list and its ranges.

![](pone.0059518.t001){#pone-0059518-t001-1}

                                                            Critical Value Range                    
  ----------------------------- --------- --------------------------------------------------------- ----------------------------------------------------------------------
  pH                               \-                               7.15                                                             7.58
  pCO~2~                          mm Hg                              20                                                               75
  pO~2~                           mm Hg                              40                                                               \-
  Glucose                        mmol/L                              2.5                                                             27.8
  Potassium                      mmol/L                             2.80                                                             6.50
  Sodium                         mmol/L                              115                                                             160
  Calcium (Total)                mmol/L                              1.6                                                             3.5
  Prothrombin time                  s                                \-                              30 (non-severe liver disease ward) or 50 (severe liver disease ward)
  Partial thromboplastin time       s                                \-                                                               80
  WBC count                      10^9^/L                             1.5                                                             50.0
  Platelet count                 10^9^/L   20 (non- hematological ward) or 10 (hematological ward)                                   1000

Critical Value Reporting {#s2b}
------------------------

In 2010, the process of critical value reporting was as follows: when a laboratory technician detects a critical value, he/she will validate the critical result by repeat testing or by checking the quality of the specimen and any historical results for the patient. For inpatients, the result will then be posted on the patient\'s Electronic Medical Record. The Laboratory Information System and the Electronic Medical Record will send a short message and a screen reminder to the physician. The Medical Order System will also send out a screen reminder to the ward nurses. The laboratory technician then phoned the nurses on the patient\'s floor to notify them of the patient\'s critical value. The nurses will then remind the physician to address the critical value result. For outpatients, the laboratory technician will inform either the patient or his/her family member using the contact phone number required for all outpatients during registration. If not successful, the physician who ordered the test will be informed. If this fails, the emergency center of the hospital will be informed of the situation. In addition, there is a reminder on the laboratory test report indicating that this is a critical result and that it is recommended that the patient contact his or her physician immediately. All phone contacts, including time, contact person and contact details will be recorded. According to the policy, we assess the critical value scope, incidence, timeliness of reporting, and effectiveness each year.

Ethics Statement {#s2c}
----------------

This study was approved by the ethics committee of the First Affiliated Hospital, College of Medicine, Zhejiang University, China, and was in accordance with the Helsinki declaration. The institutional review board waived the need for written informed consent from participants.

Source of Data {#s2d}
--------------

Using Powerbuilder 11.5 software, the raw data test results from January 1, 2010 to December 31, 2010 for 11 critical value analytes were obtained from the Laboratory Information System and saved as a Visual FoxPro DBF database. The contents of the data included specimen number, unique patient identification number, patient name, department, diagnosis, analyte, result, and report time.

Data Processing and Analysis {#s2e}
----------------------------

String data (data containing explanatory information such as "twice result", "recheck") were removed from the test results. Only numeric data were left so that test results could be compared and computed using symbols such as "\>" and/or "\<". In addition, false positive critical values, such as those caused by specimen hemolysis, were removed. The raw data were calculated and summarized using Standard Query Language, and the data were then processed using an EXCEL spreadsheet to show the distribution and P~10~, P~50~, and P~90~ interval times for each repeat critical value. Serum potassium and platelet count were chosen as examples. Data on diagnosis, length of hospital stay and patient outcome were extracted from the Electronic Medical Record to analyze the relationship between the frequency of the repeat critical values and patient outcome.

Statistical Analysis {#s2f}
--------------------

Statistical analyses were performed using SPSS version 15.0 for Windows. Frequencies, medians, quartile and percentages were used for descriptive statistics. The variable for patient outcome was categorized using four levels: healed, improved, not improved, and died. This was coded as 1, 2, 3 and 4 before statistical analysis. The relationships between the frequency of repeat critical values and the length of hospital stay and patient outcome were evaluated by Kruskal-Wallis nonparametric tests. Man-Whitney U tests were used as post hoc tests to compare between two groups. Because there were three groups for comparison, *p* = 0.05/3 = 0.0167 was used as the critical level of significance.

Results {#s3}
=======

The Incidence and Distribution of Critical Values {#s3a}
-------------------------------------------------

In the year 2010, there were approximately 3,170,000 tests for the 11 test items included in the critical value list with the total number of patients being approximately 259,000. If a patient visited both the outpatient department and inpatient department of the hospital it was calculated as two cases. Of these, 10,516 patients had 30,400 person time critical values, an incidence rate of 0.96%. Among these patients, 6,912 cases and 24,754 person time critical values were from the inpatient department and 3,604 cases and 5,646 person times critical values were from the outpatient department.

The Distribution of Single Analyte Repeat Critical Values {#s3b}
---------------------------------------------------------

The distribution of single analyte repeat critical values is shown in [Table 2](#pone-0059518-t002){ref-type="table"}. It is evident that all the 11 test items were prone to repeat critical values. The main tests for repeat critical values were white blood cell (WBC) and platelet count. Blood glucose was the least likely test to have repeat critical values. On average, each patient who experienced a critical value had it occur 2.10 times.

10.1371/journal.pone.0059518.t002

###### The distribution of single analyte repeat critical values.

![](pone.0059518.t002){#pone-0059518-t002-2}

  Analyte                        Frequency   Total patient[a](#nt101){ref-type="table-fn"}   Total person times   Average time   Repeat critical value (%)                               
  ----------------------------- ----------- ----------------------------------------------- -------------------- -------------- --------------------------- ----- ------- ------- ------ ------
  pH                                347                           89                                 43                18                    9               31     537    1057    1.97   35.4
  pCO~2~                            479                           147                                66                46                   26               89     853    2501    2.93   43.9
  pO~2~                             968                           157                                67                25                   18               42    1277    2177    1.70   24.2
  Glucose                           399                           37                                 12                3                     1                4     456     566    1.24   12.5
  Potassium                        1356                           320                               120                61                   27               29    1913    2947    1.54   29.1
  Sodium                            145                           56                                 22                11                   15               15     264     583    2.21   45.1
  Calcium                           402                           94                                 37                21                    7               24     585    1055    1.80   31.3
  Prothrombin time                 1396                           438                               136                48                   31               21    2070    3203    1.55   32.6
  Partial Thromboplastin time      1677                           266                               101                49                   41               85    2219    3657    1.65   24.4
  WBC count                         948                           419                               250               158                   106              360   2241    7159    3.19   57.7
  Platelet count                   1046                           382                               203               120                   70               208   2029    5495    2.71   48.5
  Total                            9163                          2405                               1057              560                   351              908   14444   30400   2.10   36.6

For practical reasons, each critical result here was calculated as one patient. For instance, if a patient had repeat critical values for three analytes, it was calculated as three patients. Therefore, the total number of patients (14444) in the table was more than the real number of patients (10516).

The Distribution of Multiple Analytes Repeat Critical Values {#s3c}
------------------------------------------------------------

There were 523 cases of repeat critical values for two analytes in the same patient. The combinations were mainly WBC and platelet count (372 cases), prothrombin time and partial thromboplastin time (33 cases), and platelet count and partial thromboplastin time (12 cases). There were 61 cases of repeat critical values for three analytes in the same patient; the combinations were mainly serum potassium and WBC and platelet count (11 cases), partial thromboplastin time and prothrombin time and platelet count (11 cases), and pH and pCO~2~ and pO~2~ (8 cases). Additionally, there were also several cases of repeat critical values for four or more analytes in the same patient (data not shown).

The Interval Time for Each Repeat Critical Value {#s3d}
------------------------------------------------

The P~10~, P~50~ (median), and P~90~ interval times for each repeat critical value are shown in [Table 3](#pone-0059518-t003){ref-type="table"}. The results indicated that the median intervals between different analytes varied greatly, with pH having the shortest interval (4 hours) and prothrombin time having the longest interval (120 hours).

10.1371/journal.pone.0059518.t003

###### The Interval for Each Repeat Critical Value (Hours).
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  Analyte                        P~10~   P~50~   P~90~
  ----------------------------- ------- ------- -------
  pH                               1       4      149
  pCO~2~                           1       7      96
  pO~2~                            2      24      214
  Glucose                          2      24      216
  Potassium                        3      17      260
  Sodium                           4      16      52
  Calcium                          5      22      250
  Prothrombin time                 5      120    2226
  Partial thromboplastin time      2      44      193
  WBC count                       17      68      312
  Platelet count                   9      49      240

Clinical data analysis of patients with repeat critical values of serum potassium {#s3e}
---------------------------------------------------------------------------------

There were 557 cases of repeat critical values for serum potassium in the laboratory in 2010. Of these, 71 cases were from the outpatient clinic (42 from the emergency center and 13 from the renal center) and 486 cases were from the inpatient department (130 from the hepatitis ward, 58 from the hepatopancreatobiliary surgical ward, 54 from renal ward, 50 from intensive care unit, 37 from endocrine ward, and 34 from hematologic ward). The main diagnoses for inpatients with repeat critical values for serum potassium were kidney diseases, cancer, hepatitis B with liver cirrhosis, leukemia, hypokalemia, and infection. Patients were divided into 3 groups: group A for those with only one critical value for serum potassium, group B for those with two or three critical value for serum potassium and group C for those with no less than four critical value for serum potassium. Kruskal-Wallis tests showed that there were significant differences between groups in both the length of hospital stay and patient outcome (*p*\<0.001) ([Figure 1A](#pone-0059518-g001){ref-type="fig"}, [Figure 2A](#pone-0059518-g002){ref-type="fig"}). Post hoc comparisons using a Mann-Whitney U test revealed that groups B and C had significantly longer hospital stays and a worse patient outcomes than group A (all *p*\<0.0033). Group C had significant longer hospital stays than group B, but did not differ significantly in patient outcome from group B (*p*\>0.0167). Along with the increased frequency of critical value for serum potassium, the mortality rate increased from 4.5% to 20.2%.

![The relationship between the frequency of critical values and the length of hospital stay.\
Note: (A) critical values of serum potassium. (B) critical values of platelet count. The patients were divided into 3 groups based on the frequency of the critical values: group A (1 time), group B (2--3 times), group C (≥4 times). Statistics: box plots showing the median, quartiles, and range. Kruskal-Wallis nonparametric test, *p*-values shown. Man-Whitney U tests (\*\* p\<0.0033).](pone.0059518.g001){#pone-0059518-g001}

![The relationship between the frequency of critical values and patient outcomes.\
Note: (A) critical values of serum potassium. (B) critical values of platelet count. The patients were divided into 3 groups based on the frequency of the critical values: group A (1 time), group B (2--3 times), group C (≥4 times). Statistics: Kruskal-Wallis nonparametric test, *p*-values shown. Man-Whitney U tests (\*\*, *p*\<0.0033. NS, not significant).](pone.0059518.g002){#pone-0059518-g002}

Clinical data analysis of patients with repeat critical values of platelet count {#s3f}
--------------------------------------------------------------------------------

There were 983 cases of repeat critical values for platelet count in the laboratory in 2010. Of these, 219 cases were from the outpatient clinic (104 from the emergency center and 80 from the hematology clinic) and 764 cases were from the inpatient department (360 from the hematology ward, 97 from the hepatitis ward, 92 from the intensive care unit, and 75 from the hepatopancreatobiliary surgical ward). The main diagnoses for those inpatients with repeat critical values for platelet count were platelet diseases, acute and chronic leukemia, liver cirrhosis, gastrointestinal bleeding, and cancer. Patients were divided into 3 groups: group A for those with only one critical value for platelet count, group B for those with two or three critical value for platelet count and group C for those with no less than four critical value for platelet count. Kruskal-Wallis tests showed that there were significant difference between groups in both the length of hospital stay and patient outcome (*p*\<0.001) ([Figure 1B](#pone-0059518-g001){ref-type="fig"}, [Figure 2B](#pone-0059518-g002){ref-type="fig"}). Post hoc comparisons using Mann-Whitney U test revealed that group B and group C had significantly longer hospital stays than group A. Group C had significant longer hospital stays than group B (all *p*\<0.0033) and also had significantly worse patient outcomes than groups A and B. Group A did not differ significantly in patient outcome from group B (*p*\>0.0167). Along with the increased frequency of critical value for platelet count, the mortality rate increased from 3.3% to 9.9%.

Discussion {#s4}
==========

In 2010, the incidence rate of critical value in the clinical laboratory of our hospital was 0.96%, slightly higher than what was reported in the literature but still within the limit of less than 1% [@pone.0059518-Howanitz1], [@pone.0059518-Dighe2]. The high rate of critical value might relate to the economic level of China. Without insurance coverage, some patients from the countryside may not seek medical treatment until their condition is severe. Additionally, as a tertiary hospital, many patients are transferred here from local hospitals, so we have a relatively high number and percentage of severe and emergency patients and thus more critical values.

As [Table 2](#pone-0059518-t002){ref-type="table"} shows, all analytes in the critical value list had repeat critical values and on average each patient with a critical value had it occur 2.10 times. In the literature, it was reported that, on average, a patient with critical value for serum sodium could have it occur 3.53 times, and this number was 3.31 for serum calcium [@pone.0059518-Howanitz2], [@pone.0059518-Howanitz3]. Our findings suggest that the occurrence of repeat critical values were related to certain diseases and wards. For instance, our patients with repeat critical values for platelet count were mainly from the hematological ward. This suggests that laboratories should make every effort to consult with clinicians in these wards to tailor the handling of repeat critical values in the patient population and to meet the needs of both clinicians and patients. As another measure, a population specific critical value range could be considered. For instance, in 2008, the lower threshold of platelet count in our hospital was changed to 10×10^9^/L for patients in the hematological ward after approval from the Hospital Quality Control Committee [@pone.0059518-Kost1]. Without this change, the number of critical values for platelet count in this study would have been even more. We also have population specific critical value ranges for prothrombin time in the severe liver disease ward. Until now, we did not have different standards for WBC thresholds aimed at patients from the hematological ward. As a result, the average time of critical value for WBC was 3.19, with an approximate repeat critical value rate of 57.7%. This put WBC on the top of the list for both the number of critical value and repeat critical values. Although it is good practice to set population specific critical value ranges, it is difficult to do so in some wards, such as the intensive care unit and emergency center because of the wide range of diseases treated therein.

Blood glucose had the lowest occurrence of repeat critical values among our tests. From [Table 2](#pone-0059518-t002){ref-type="table"}, we can see that, on average, the critical value of glucose occurred 1.24 times. This was likely related to the adoption of point of care tests for blood glucose in our hospital. A glucometer was widely used for initial screening and later for monitoring of blood glucose by registered nurses, due to the advantages of simplicity and speed. Point of care test results were not included in the scope of critical value management in our hospital. This caused few repeat critical values of blood glucose in the results.

We also found many multiple analytes repeat critical values in the same patient during our analysis. The main combinations of two analyte repeat critical values were WBC and platelet count and partial thromboplastin time and prothrombin time. These reflected problems of the same system, such as the hematological system or the blood coagulation system. These tests were usually performed by the same laboratory division and the same laboratory technician can complete the reporting of multiple analyte critical results, thus reducing the influence on the workload of both the clinic and laboratory. When a patient has three or more analytes repeat critical values, such as the combination of potassium and WBC and platelet count or partial thromboplastin time and prothrombin time and platelet count, it usually indicates an extreme disorder of multiple systems, an even more critical situation for the patient. When there are more than two analytes repeat critical values for the same patient, it usually involves two or more laboratory divisions and technicians. In this case, several phone calls are required to complete the critical results reporting. Given the severe situation, more clinical attention should be paid to patients with multiple analytes repeat critical values. Currently there are no guidelines on how to report such critical results; we suggest that each critical value should be reported to promote patient safety.

The interval between the critical values of the same analyte and same patient is a very important part of the decision of whether to report all repeat critical values or not. If the intervals are short, the medical staff are still on the same shift, and they are clear about the patient\'s condition, it may not be necessary to report all the repeat critical values. On the contrary, if the intervals are long, it is usually necessary to report the critical values in order to remind physicians of the patient\'s changed condition. Our results showed that the median interval of repeat critical values for different analytes varied from 4 to 120 hours, with most analytes having a median interval longer than 8 hours. In this case, different laboratory technicians, nurses and physicians would be involved, and some of them may not know the state of previous critical values. We suggest these repeat critical values should be reported each time to give clinicians adequate information. Although we chose 8 hours as the reporting cut-off point, others may feel more comfortable with a longer time frame, such as the first of a series of values within 12 or 24 hours requiring notification. It is good practice to establish an individualized reporting strategy aimed at each specific analyte based on its median interval. For instance, blood pH (4 hours) and pCO~2~ (7 hours) had the shortest median interval of repeat critical values. We consider it fine not to call repeat critical values of these two analytes within 8 hours.

There is little data on the relationship between the frequency of repeat critical values and patient outcome. This information is important when optimizing reporting policy. Two indicators were chosen based on the literature: length of hospital stay and patient outcome expressed as healed, improved, not improved or died [@pone.0059518-Howanitz2], [@pone.0059518-Howanitz3]. In 2010, we reported all repeat critical values with a combination of sending short messages to physicians and making phone call to the ward nurses regardless of the previous results. Using serum potassium and platelet count as examples, our results demonstrated that along with increased frequencies of repeat critical values, patients had a longer hospital stay and an increased mortality rate.

Potassium plays an important role in maintaining cellular polarization and is critical for the transmission of electrical impulse through the myocardium. Hypokalemia is associated with heightened ventricular excitability and an increased risk of ventricular arrhythmias. Hyperkalemia disturbs cardiac conduction and can cause arrhythmias and precipitate cardiac arrest [@pone.0059518-Mirzoyev1]. Goyal et al. reported that serum potassium values of less than 3.5 or more than 5.0 mEq/L were associated with a high adverse cardiac event and mortality rate in patients with acute myocardial infarction [@pone.0059518-Goyal1]. Hypokalemia was also found to be a predictor of serious peri- and postoperative arrhythmias [@pone.0059518-Sanjay1]. As shown in [Figures 1A](#pone-0059518-g001){ref-type="fig"} and [2](#pone-0059518-g002){ref-type="fig"} A, an increase in the number of repeat critical value s for serum potassium was closely related to an increase in mortality (from 4.5% to 9.9% and 10.2%) with a decrease in healing rating (from 17.7% to 10.7% and 7.7%). Similarly, platelets help the blood clot. If the number of platelets is too high, blood clots can form which may obstruct blood vessels and result in events such as stroke, myocardial infarction, or pulmonary embolism. However, if the number of platelets is too low excessive bleeding can occur. Studies have found a strong negative correlation between the admission platelet count and mortality for ICU patients [@pone.0059518-Greinacher1]. Our results also indicate the critical condition of those patients with repeat critical values of platelet count. This is in accordance with the original definition of critical value by Lundberg, where critical condition implies that constant clinical attention is required.

From a laboratory management perspective, more attention should be paid to the management of repeat critical values. In the literature, it is quite common that not all repeat critical values are reported. This is concerning, as there is very little research evidence showing that it is safe to do so. Clinicians may not be fully clear on why certain critical values are not reported, which can lead to undesirable consequences if intervention is delayed. A repeat low platelet count can be a critical value even if it is an expected finding because it can influence patient management and may prompt physicians to withhold or delay necessary invasive interventions, reduce the intensity of anticoagulation, or order prophylactic platelet transfusion. A Q-track study reported that the practice of mandatory notification to caregivers of repeat inpatient critical values was associated with improved overall performance in critical value reporting when compared to institutions that had a policy to not call back repeat critical values [@pone.0059518-Wagar2]. In addition, reporting all repeat critical values is a good indication of an increased level of vigilance, which is essential for sustaining patient safety efforts [@pone.0059518-Wagar2]. Based on our results, at least regarding serum potassium and platelet count, the practice of not calling each repeat critical value is unwarranted and thus requires careful evaluation.

We believe our findings are representative of critical patients in large tertiary hospitals in developing countries. Due to the unique setting, they may not be representative of small or rural hospitals in the US or other Western countries. To the best of our knowledge, this is the first report on the distribution and interval of repeat critical values from China, and one of very few such reports internationally. We also know of no previous studies reporting the association of the frequency of repeat critical values on patient outcome. Although this study shed some light on reporting policies for repeat critical values, it remains uncertain which policy is most beneficial for patient outcome. Future studies testing the effectiveness of different policy approaches are highly recommended.

Conclusion {#s4a}
----------

We retrospectively analyzed the laboratory repeat critical values at a large tertiary hospital in China. Patients can have a number of repeat critical values for different tests, and the frequencies of such values are closely related to patient outcomes. It is necessary for each laboratory to have a policy on how to handle repeat critical values based on a number of factors such as interval time and the nature of the test item, combined with reporting methods and hospital characteristics. This will clarify laboratory technician responsibilities and establish consistency in performance. Theoretically, it is possible not to call each repeat critical value, and it is often difficult to develop a policy that is tailored to different situations, especially when a laboratory technician has limited information available and a short period of time to make a reporting decision. A generic policy that covers all patients is practical because it is easiest for technicians to implement and causes no errors in judgment. To ensure patient safety, a careful evaluation is warranted if a laboratory adopts a policy of not to call each repeat critical value.
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